key: cord-0831595-dvyolvr1
authors: Mishra, Yogendra; Pathak, Basant Kumar; Mohakuda, Sourya Sourabh; Tilak, T.V.S.V.G.K.; Sen, Soham; P, Harikrishnan; Singh, Rhea; Singh, Anchit Raj
title: Relation of D-dimer levels of COVID-19 patients with diabetes mellitus
date: 2020-10-01
journal: Diabetes Metab Syndr
DOI: 10.1016/j.dsx.2020.09.035
sha: e18c2b7206853b31037acd9bc361ec436106a8ca
doc_id: 831595
cord_uid: dvyolvr1

BACKGROUND AND AIMS: Diabetes is a frequent comorbidity in patients with Severe COVID-19 infection associated with a worse prognosis. Hypercoagulability with elevation in D-dimer levels has been demonstrated in patients with COVID-19. This study aims to study D-dimer levels in people with diabetes compared to those without diabetes among patients with COVID-19 infection. METHODS: In this observational study 98 moderate and severely ill patients with COVID-19 infection were included at a dedicated COVID hospital. The study group was divided into patients with diabetes and without diabetes. Peak D-dimer was measured in both the groups and compared using appropriate statistical tests. RESULTS: In our study peak D-dimer levels were 1509 ± 2420 ng/mL (Mean ± SD) in people with diabetes and 515 ± 624 ng/mL (Mean ± SD) in patients without diabetes. Patients with diabetes had higher D-dimer levels which were statistically significant. CONCLUSIONS: This study shows COVID-19 patients with diabetes had significantly higher D-dimer levels. Therefore, it is possible that COVID-19 infection with diabetes is more likely to cause hypercoagulable state with a worse prognosis. However clinical implications of these findings will need to be seen in further studies.

infection. 48 Methods: In this observational study 98 moderate and severely ill patients with COVID-19 49 infection were included at a dedicated COVID hospital. The study group was divided into 50 patients with diabetes and without diabetes. Peak D-dimer was measured in both the groups 51 and compared using appropriate statistical tests. 52 Results: In our study peak D-dimer levels were 1509±2420 ng/mL (Mean±SD) in people with 53 diabetes and 515±624 ng/mL (Mean±SD) in patients without diabetes. Patients with 54 diabetes had higher D-dimer levels which were statistically significant. 

This cross-sectional study was conducted at a dedicated COVID hospital in North India from 98 death. Exclusion criteria were age <18yrs, patients with a pre-existing history of venous 106 thromboembolism, or on anticoagulants, and pregnancy. Written informed consent was taken. 107 This study was approved by the Institutional Ethics Committee. 

An interactive web-based dashboard to track COVID-19 in real 225 time

Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 231 Pneumonia in Wuhan, China

Preliminary 233 Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients 234 with Coronavirus Disease

Characteristics of and Important Lessons from the Coronavirus 236 Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from 237 the Chinese Center for Disease Control and Prevention

Corona Viruses , and Diabetes Mellitus Ranganath Muniyappa and Sriram

National Institute of Diabetes and Digestive and Kidney Diseases , N

Viral Shedding in MERS Patients during MERS-CoV Outbreak in South Korea

Endocrine and metabolic link 251 to coronavirus infection

Prevalence and impact of cardiovascular 253 metabolic diseases on COVID-19 in China

Clinical characteristics of coronavirus 255 disease 2019 in China

Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A 258

Comprehensive Evaluation of Clinical and Basic Evidence

D-dimer levels on admission to predict 260 in-hospital mortality in patients with Covid-19

The stimulation of thrombosis by hypoxia

264 Diabetes mellitus: The linkage between oxidative stress, inflammation, 265 hypercoagulability and vascular complications

Ministry of Health and Family Welfare

Version 3